370 related articles for article (PubMed ID: 3307061)
1. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
[TBL] [Abstract][Full Text] [Related]
2. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
Roth D; Milgrom M; Esquenazi V; Fuller L; Burke G; Miller J
Transplantation; 1989 Feb; 47(2):278-81. PubMed ID: 2645712
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
5. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
[TBL] [Abstract][Full Text] [Related]
6. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.
Hricik DE; Bartucci MR; Moir EJ; Mayes JT; Schulak JA
Transplantation; 1991 Feb; 51(2):374-7. PubMed ID: 1994531
[TBL] [Abstract][Full Text] [Related]
7. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
9. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry M; Ferguson RM
Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
[TBL] [Abstract][Full Text] [Related]
10. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
[TBL] [Abstract][Full Text] [Related]
11. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
Wrenshall LE; Matas AJ; Canafax DM; Min DI; Sibley RJ; Dunn DL; Payne WD; Sutherland DE; Najarian JS
Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors.
Sumrani NB; Delaney V; Ding ZK; Davis R; Daskalakis P; Friedman EA; Butt KM; Hong JH
Transplantation; 1991 Feb; 51(2):343-7. PubMed ID: 1994525
[TBL] [Abstract][Full Text] [Related]
14. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
[TBL] [Abstract][Full Text] [Related]
15. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
16. High incidence of post-transplant diabetes mellitus in Kuwait.
Johny KV; Nampoory MR; Costandi JN; Gupta RK; Ninan VT; Samhan M; Muzairai I; Al-Mousawi M
Diabetes Res Clin Pract; 2002 Feb; 55(2):123-30. PubMed ID: 11796178
[TBL] [Abstract][Full Text] [Related]
17. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Hesse UJ; Fryd DS; Chatterjee SN; Simmons RL; Sutherland DE; Najarian JS
Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia after renal transplantation.
Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
